TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Aromatic Ring Medications, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Aromatic Ring Medications technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Aromatic Ring Medications

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Aromatic Ring Medications industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Aromatic Ring Medications industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Aromatic Ring Medications industry

Novel Treatment Of Mitochondrial DiseasesKHONDRIONApr 10, 2024SULFATEQ
Once Daily Formulation Of LacosamideUCB PHARMAMay 10, 2023GENERICS UK
Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine DerivativeMURRAY & POOLE ENTERPRISESApr 21, 2022TEVA PHARMACEUTICALS
Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine DerivativeMURRAY & POOLE ENTERPRISESApr 20, 2022PHARMASCIENCE
Extended Release Suspension CompositionsSUN PHARMACEUTICAL INDUSTRIESAug 11, 2021RECKITT BENCKISER HEALTH
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant EffectUCB PHARMAMay 3, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
Modified Release Formulation Of LacosamideLUPINJul 16, 2020JAMES POOLE
Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDORMar 19, 2020BEIERSDORF
Adhesive Preparation Composition Obtained By Blending Drug, Organic Solvent, Lipophilic Ointment Base, And PowderMEDRXFeb 11, 2020HOFFMANN EITLE
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGENJun 26, 2019GLAXOSMITHKLINE UK

To stay ahead in the competitive Aromatic Ring Medications industry, companies are constantly innovating. Here are the top patents facing oppositions in the Aromatic Ring Medications industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 8, 2014Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN4
Jul 21, 2021Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine DerivativeMURRAY & POOLE ENTERPRISES2
Aug 10, 2022Once Daily Formulation Of LacosamideUCB PHARMA1
Aug 29, 2018Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaARES TRADING1
May 11, 2022Adhesive Preparation Composition Obtained By Blending Drug, Organic Solvent, Lipophilic Ointment Base, And PowderMEDRX1
Oct 16, 2019Modified Release Formulation Of LacosamideLUPIN1
Aug 5, 2020Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant EffectUCB PHARMA1
Oct 18, 2017C7-Fluoro Substituted Tetracycline CompoundsTETRAPHASE PHARMACEUTICALS1
Jul 6, 2022Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDOR1
Dec 20, 2023Extended Release Suspension CompositionsSUN PHARMACEUTICAL INDUSTRIES1